PTHrP	O
drives	O
breast	B-Cancer
tumor	I-Cancer
initiation	O
,	O
progression	O
,	O
and	O
metastasis	O
in	O
mice	O
and	O
is	O
a	O
potential	O
therapy	O
target	O
.	O

Parathyroid	O
hormone	O
-	O
related	O
protein	O
(	O
PTHrP	O
)	O
is	O
a	O
secreted	O
factor	O
expressed	O
in	O
almost	O
all	O
normal	O
fetal	B-Tissue
and	O
adult	B-Tissue
tissues	I-Tissue
.	O

It	O
is	O
involved	O
in	O
a	O
wide	O
range	O
of	O
developmental	O
and	O
physiological	O
processes	O
,	O
including	O
serum	B-Organism_substance
calcium	O
regulation	O
.	O

PTHrP	O
is	O
also	O
associated	O
with	O
the	O
progression	O
of	O
skeletal	B-Cancer
metastases	I-Cancer
,	O
and	O
its	O
dysregulated	O
expression	O
in	O
advanced	O
cancers	B-Cancer
causes	O
malignancy	O
-	O
associated	O
hypercalcemia	O
.	O

Although	O
PTHrP	O
is	O
frequently	O
expressed	O
by	O
breast	B-Cancer
tumors	I-Cancer
and	O
other	O
solid	B-Cancer
cancers	I-Cancer
,	O
its	O
effects	O
on	O
tumor	B-Cancer
progression	O
are	O
unclear	O
.	O

Here	O
,	O
we	O
demonstrate	O
in	O
mice	O
pleiotropic	O
involvement	O
of	O
PTHrP	O
in	O
key	O
steps	O
of	O
breast	B-Cancer
cancer	I-Cancer
-	O
it	O
influences	O
the	O
initiation	O
and	O
progression	O
of	O
primary	B-Cancer
tumors	I-Cancer
and	O
metastases	B-Cancer
.	O

Pthrp	O
ablation	O
in	O
the	O
mammary	B-Tissue
epithelium	I-Tissue
of	O
the	O
PyMT	O
-	O
MMTV	O
breast	B-Cancer
cancer	I-Cancer
mouse	O
model	O
caused	O
a	O
delay	O
in	O
primary	B-Cancer
tumor	I-Cancer
initiation	O
,	O
inhibited	O
tumor	B-Cancer
progression	O
,	O
and	O
reduced	O
metastasis	O
to	O
distal	B-Multi-tissue_structure
sites	I-Multi-tissue_structure
.	O

Mechanistically	O
,	O
it	O
reduced	O
expression	O
of	O
molecular	O
markers	O
of	O
cell	B-Cell
proliferation	O
(	O
Ki67	O
)	O
and	O
angiogenesis	O
(	O
factor	O
VIII	O
)	O
,	O
antiapoptotic	O
factor	O
Bcl	O
-	O
2	O
,	O
cell	B-Cell
-	O
cycle	O
progression	O
regulator	O
cyclin	O
D1	O
,	O
and	O
survival	O
factor	O
AKT1	O
.	O

PTHrP	O
also	O
influenced	O
expression	O
of	O
the	O
adhesion	O
factor	O
CXCR4	O
,	O
and	O
coexpression	O
of	O
PTHrP	O
and	O
CXCR4	O
was	O
crucial	O
for	O
metastatic	O
spread	O
.	O

Importantly	O
,	O
PTHrP	O
-	O
specific	O
neutralizing	O
antibodies	O
slowed	O
the	O
progression	O
and	O
metastasis	O
of	O
human	O
breast	B-Cancer
cancer	I-Cancer
xenografts	I-Cancer
.	O

Our	O
data	O
identify	O
what	O
we	O
believe	O
to	O
be	O
new	O
functions	O
for	O
PTHrP	O
in	O
several	O
key	O
steps	O
of	O
breast	B-Cancer
cancer	I-Cancer
and	O
suggest	O
that	O
PTHrP	O
may	O
constitute	O
a	O
novel	O
target	O
for	O
therapeutic	O
intervention	O
.	O

